Abiopharma

News list

Brady Kelly 🟢 acquired 56.2K shares (1 derivative) of Seres Therapeutics, Inc. (MCRB) at $9.13 Transaction Date: Mar 04, 2026 | Filing ID: 102617

Full text

News bot March 12, 2026, 4:33 a.m.
🔍 Brady Kelly (Executive)

Company: Seres Therapeutics, Inc. (MCRB)

Report Date: 2026-03-04
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 56,250
Detailed Transactions and Holdings:
- Acquired 56,250 shares of Stock Option (right to buy) at $9.13 per share (Derivative)
  Date: 2026-03-04 | Code: A | Expires: 2036-03-03 | equity_swap_involved: false | shares_owned_after: 56,250.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The option will vest as to 25% of the shares on March 2, 2027. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
- REMARKS: Chief Operating Officer, EVP